AstraZeneca
AstraZeneca launches prostate cancer app
August 7, 2012Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate
AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …
AstraZeneca launches virtual research laboratory
July 31, 2012Medical Communications Assay Depot, AstraZeneca, R&D, virtual
AstraZeneca and partner Assay Depot have launched a virtual research laboratory aimed at helping its scientists create R&D collaborations. The …
IT problems at Swedish plant affect AstraZeneca
July 27, 2012Manufacturing and Production AstraZeneca, Nexium, Symbicort, financials
Software problems at a manufacturing facility operated by AstraZeneca in Sweden are having a material impact on the business, pegging …
AstraZeneca’s Fluenz chosen for wider flu immunisation
July 26, 2012Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune
The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …
AstraZeneca sees big sales drop in Q2
July 26, 2012Sales and Marketing AstraZeneca, Brennan, Brilinta, Q2, Seroquel
AstraZeneca has today reported a large drop in revenue for the second quarter. The firm has been hit by major …
‘Golden parachute’ for AZ’s David Brennan
July 17, 2012Sales and Marketing AstraZeneca, David Brennan, GMB
David Brennan, the former chief executive of AstraZeneca, could receive more than £4million as a payout after being ousted from …
AZ sets up Alzheimer’s research collaborative
July 13, 2012Research and Development Alzheimer's, AstraZeneca, neuroscience
AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …
AstraZeneca buys neuroscience molecules
July 13, 2012Research and Development Alzheimer's, AstraZeneca, neuroscience
AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …
AstraZeneca and BMS buy Amylin for $7 billion
July 2, 2012Sales and Marketing Amylin, AstraZeneca, BMS
AstraZeneca and Bristol-Myers Squibb have struck a deal to purchase diabetes specialist Amylin in a complicated agreement worth $7 billion. …
Ireland agrees deal on medicines
June 28, 2012Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing
Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …
AstraZeneca buys Ardea Biosciences
June 22, 2012Research and Development, Sales and Marketing Abbott, Ardea Biosciences, AstraZeneca, Bayer, Humira, Takeda
AstraZeneca has completed its acquisition of US firm Ardea Biosciences in a $1.26 billion deal that it hopes will shore …
Analysts want AstraZeneca-AbbVie tie-up
June 20, 2012Sales and Marketing AbbVie, Abbott, AstraZeneca, merger
Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future …
AstraZeneca swings axe at Swedish plant
June 14, 2012Sales and Marketing AstraZeneca, Brennan, Sweden, Södertälje, cuts
AstraZeneca will be cutting 400 jobs from its facility in Sweden, the company has confirmed. Speaking to the TT news …
Public-private alliance to discover new antibiotics
May 25, 2012AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection
A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …
Targacept cuts workforce
May 1, 2012Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept
The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
